We supported a top 10 pharma in creating meaningful and actionable Competitor Intelligence insights in the gene therapy space​

Client Challenge

Haemophilia and GT environment ​is in its infancy, with very few approved available products

Competitor actions and the results ​ of individual HTAs/coverage ​ decisions can have a significant ​ impact on the wider landscape​

​Our client was keen to understand competitors’ pricing and market access activities as well as a general overview ​ of the evolving gene therapy treatment environment, using this to support management decision making​

P4A Solution

P4A developed a report that incorporated six key areas of strategic importance​

  1. GT policy & HTA processes: today & future
  2. General competitor corporate news
  3. Competitor pricing strategy and HTA outcomes, access models
  4. Competitor strategies on stakeholder engagement and site selection
  5. Competitor manufacturing, logistics & supply model
  6. Competitor GT organizational build

The Successful Outcome

Global and European management teams were appraised of competitor activity and were better able to shape asset development

Confidence in management decision making

P4A fully met our needs and showed both flexibility and strong technical capabilities to deliver a polished product on time and budget!​ ​
PHI Senior Director Rare Disease​